Stockscreener 앱 받기
1.63
1.24%
0.02
전일 마감가:
$1.61
열려 있는:
$1.66
하루 거래량:
107.36K
Relative Volume:
0.06
시가총액:
$7.06M
수익:
$2.46M
순이익/손실:
$-13.40M
주가수익비율:
-0.1682
EPS:
-9.69
순현금흐름:
$-7.34M
1주 성능:
+16.43%
1개월 성능:
+4.49%
6개월 성능:
-29.44%
1년 성능:
-55.73%
1일 변동 폭
$1.57
$1.69
1주일 범위
$1.45
$1.735
52주 변동 폭
$1.00
$11.70
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
명칭
Intelligent Bio Solutions Inc
전화
646-233-6971
주소
135 W 41ST ST,, NEW YORK
INBS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INBS
Intelligent Bio Solutions Inc
|
1.63 | 7.06M | 2.46M | -13.40M | -7.34M | -9.69 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Intelligent Bio Solutions Inc 주식(INBS)의 최신 뉴스
Intelligent Bio Solutions completes fingerprint drug screening system study - Yahoo! Voices
Intelligent Bio Solutions Advances Fingerprint Drug Testing - TipRanks
Intelligent Bio : Achieves 94.1% Accuracy in Method Comparison Study, Following Positive PK Study Results Form 8 K - Marketscreener.com
Intelligent Bio Solutions Achieves 94.1% Accuracy in Method Comparison Study, Following Positive PK Study Results - The Manila Times
Intelligent Bio Solutions Inc. Achieves 94.1% Accuracy in Method Comparison Study, Following Positive Pk Study Results - Marketscreener.com
Intelligent Bio Solutions to Participate in the Noble Capital Markets 20th Annual Emerging Growth Equity Conference - Marketscreener.com
Intelligent Bio Solutions to Participate in the Noble Capital Markets' 20th Annual Emerging Growth Equity Conference - The Manila Times
Intelligent Bio Solutions to Participate in the Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference - Marketscreener.com
Intelligent Bio Solutions to Present at Noble Capital's 2024 Growth Conference | INBS Stock News - StockTitan
Intelligent Bio Solutions raises $250k via stock sales - Investing.com
INBS (Intelligent Bio Solutions) Peter Lynch Fair Value : $-443.54 (As of Nov. 21, 2024) - GuruFocus.com
Intelligent Bio Solutions raises $250k via stock sales By Investing.com - Investing.com UK
INBS (Intelligent Bio Solutions) Inventory Turnover : 0.69 (As of Sep. 2024) - GuruFocus.com
Intelligent Bio Solutions Announces Study Results and Stock Sale - TipRanks
INBS (Intelligent Bio Solutions) Price-to-Free-Cash-Flow : N/A (As of Nov. 20, 2024) - GuruFocus.com
INBS (Intelligent Bio Solutions) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Sep. 2024) - GuruFocus.com
Intelligent Bio : INBS PK Study Results Video - Marketscreener.com
INBS (Intelligent Bio Solutions) EBITDA per Share : $-30.36 (TTM As of Sep. 2024) - GuruFocus.com
INBS (Intelligent Bio Solutions) Total Assets : $11.73 Mil (As of Sep. 2024) - GuruFocus.com
INBS (Intelligent Bio Solutions) PensionAndRetirementBenefi - GuruFocus.com
INBS (Intelligent Bio Solutions) Price-to-Operating-Cash-Fl - GuruFocus.com
INBS Stock Declines Despite Positive Results of Pharmacokinetic Study - MSN
Alyeska Investment Group's Strategic Acquisition of Intelligent Bio Solutions Inc Shares - GuruFocus.com
Intelligent gears up for FDA approval of fingerprint drug detection device - Yahoo Finance
INBS advances in drug detection with fingerprint technology By Investing.com - Investing.com Australia
Intelligent Bio Solutions Inc. Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission - Marketscreener.com
INBS advances in drug detection with fingerprint technology - Investing.com
Intelligent Bio Solutions (INBS) Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission - StreetInsider.com
Intelligent Bio Solutions Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission - GlobeNewswire
Intelligent Bio Solutions Hits Major Breakthrough in Drug Detection Study, FDA Filing Next | INBS Stock News - StockTitan
Intelligent Bio Solutions First Quarter 2025 Earnings: US$0.70 loss per share (vs US$12.49 loss in 1Q 2024) - Yahoo Finance
Intelligent Bio Solutions Inc. (INBS) Quarterly 10-Q Report - Quartzy
INBSIntelligent Bio Solutions Inc. Latest Stock News & Market Updates - StockTitan
Integra Lifesciences (IART) Stock Sees Sharp 5.09% Decline Amid Market Fluctuations - GuruFocus.com
INTELLIGENT BIO SOLUTIONS INC. SEC 10-Q Report - TradingView
Intelligent Bio Solutions Reports Fiscal 2025 First Quarter Financial Results and Operational Highlights - The Manila Times
ConnectM to Participate in the 13th Annual Roth Technology Conference - The Manila Times
Intelligent Bio Solutions Revenue Surges 20% QoQ, FDA Study Milestone Achieved | INBS Stock News - StockTitan
Intelligent Bio Solutions Partners With B2i Digital to Amplify Investor Outreach - Yahoo Finance
Intelligent Bio Solutions Inc (INBS-Q) QuotePress Release - The Globe and Mail
Intelligent Bio Solutions partners with B2i Digital for marketing push - Investing.com
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.58% - MSN
Intelligent Bio Solutions Partners with B2i Digital to Enhance Investor Engagement - EIN News
Intelligent Bio Solutions partners with B2i Digital for marketing push By Investing.com - Investing.com UK
Intelligent Bio Solutions Partners with B2i Digital to Amplify Investor Outreach - The Manila Times
Lisata Therapeutics to Participate in Upcoming November 2024 Industry and Investor Events - The Manila Times
Intelligent Bio Solutions reports revenue growth and strategic expansion By Investing.com - Investing.com South Africa
Intelligent Bio Solutions reports revenue growth and strategic expansion - Investing.com
Intelligent Bio Solutions Announces Preliminary Unaudited Fiscal 2025 First Quarter Revenue Results - The Manila Times
TeraWulf Schedules Conference Call for Third Quarter 2024 Financial Results - The Manila Times
Intelligent Bio Solutions Inc. Provides Revenue Guidance for the First Quarter Ended September 30, 2024 - Marketscreener.com
Intelligent Bio Solutions Inc (INBS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.65%
자본화:
|
볼륨(24시간):